Nanjing Hicin Pharmaceutical Co Ltd (300584) — Net Asset Momentum
Nanjing Hicin Pharmaceutical Co Ltd (300584) recorded a net asset momentum of 5.9% as of December 2025, with net assets of CN¥1.10 Billion CNY. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See defensive interval ratio of Nanjing Hicin Pharmaceutical Co Ltd to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Nanjing Hicin Pharmaceutical Co Ltd Net Asset Momentum (2012–2025)
This chart tracks Nanjing Hicin Pharmaceutical Co Ltd's year-over-year net asset growth across 14 annual reporting periods from 2012 to 2025. The most recent momentum reading is +5.9%, with net assets of CN¥1.10 Billion CNY as of December 2025. Read Nanjing Hicin Pharmaceutical Co Ltd balance sheet liabilities for a breakdown of total debt and financial obligations.
Annual Net Asset History for Nanjing Hicin Pharmaceutical Co Ltd (2012–2025)
The table below shows the complete annual net asset history for Nanjing Hicin Pharmaceutical Co Ltd from 2012 to 2025, covering 14 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see Nanjing Hicin Pharmaceutical Co Ltd stock valuation.
| Year | Net Assets (CNY) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | CN¥1.10 Billion | CN¥1.53 Billion | CN¥432.26 Million | ▲ +5.9% |
| 2024 | CN¥1.04 Billion | CN¥1.46 Billion | CN¥426.37 Million | ▲ +5.1% |
| 2023 | CN¥987.50 Million | CN¥1.41 Billion | CN¥421.37 Million | ▲ +3.9% |
| 2022 | CN¥950.57 Million | CN¥1.29 Billion | CN¥343.38 Million | ▲ +0.2% |
| 2021 | CN¥948.48 Million | CN¥1.30 Billion | CN¥353.53 Million | ▲ +39.7% |
| 2020 | CN¥678.97 Million | CN¥906.52 Million | CN¥227.55 Million | ▲ +3.8% |
| 2019 | CN¥653.98 Million | CN¥869.18 Million | CN¥215.19 Million | ▲ +12.6% |
| 2018 | CN¥580.93 Million | CN¥794.19 Million | CN¥213.26 Million | ▲ +12.2% |
| 2017 | CN¥517.68 Million | CN¥632.30 Million | CN¥114.61 Million | ▲ +87.5% |
| 2016 | CN¥276.11 Million | CN¥370.78 Million | CN¥94.66 Million | ▲ +17.5% |
| 2015 | CN¥235.08 Million | CN¥322.63 Million | CN¥87.55 Million | ▲ +17.5% |
| 2014 | CN¥200.15 Million | CN¥293.78 Million | CN¥93.63 Million | ▲ +20.6% |
| 2013 | CN¥165.93 Million | CN¥241.42 Million | CN¥75.49 Million | ▲ +25.1% |
| 2012 | CN¥132.65 Million | CN¥190.67 Million | CN¥58.03 Million | — |